Ultrasonic atomization and subsequent desolvation for monoclonal antibody (mAb) to the glycoprotein (GP) IIIa receptor into drug eluting stent

References

• Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents. Adv Drug Deliv Rev 2006; 58: 387–401
   PubMed Web of Science ®Google Scholar
• Aggarwal RK, Ireland DC, Azrin MA, Ezekowitz MD, deBono DP, Gershlick AH. Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody. Circulation 1996; 94: 3311–3317
   PubMed Web of Science ®Google Scholar
• Albertini B, Passerini N, Rodriguez L. Evaluation of ultrasonic atomization as a new approach to prepare ionically cross-linked chitosan microparticles. J Pharm Pharmacol 2005; 57: 821–829
   PubMed Web of Science ®Google Scholar
• Babapulle MN, Eisenberg MJ. Coated scents for the prevention of restenosis: Part II. Circulation 2002; 106: 2859–2866
   PubMed Web of Science ®Google Scholar
• Baron JH, Gershlick AH, Hogrefe K, Armstrong J, Holt CM, Aggarwal RK, et al. In vitro evaluation of c7E3-Fab (ReoPro (TM)) eluting polymer-coated coronary stents. Cardiovasc Res 2000; 46: 585–594
   PubMed Web of Science ®Google Scholar
• Bittner B, Kissel T. Ultrasonic atomization for spray drying: A versatile technique for the preparation of protein loaded biodegradable microspheres. J Microencapsulation 1999; 16: 325–341
   PubMed Web of Science ®Google Scholar
• Blanco-Prieto MJ, Campanero MA, Besseghir K, Heimgatner F, Gander B. Importance of single or blended polymer types for controlled in vitro release and plasma levels of a somatostatin analogue entrapped in PLA/PLGA microspheres. J Contr Rel 2004; 96: 437–448
   PubMed Web of Science ®Google Scholar
• Boland ED, Pawlowski KJ, Barnes CP, Simpson DG, Wnek GE, Bowlin GL. Electrospinning of bioresorbable polymers for tissue engineering scaffolds. Presented at 226th National Meeting of the American-Chemical-Society. New York 2003
   Google Scholar
• Brooks RA, Di Chiro G. Slice geometry in computer assisted tomography. J Comput Tomogr 1977; 1: 191–199
   Google Scholar
• Ding N, Helmus M. 2006, USA Patent No. US2006088654-A1
   Google Scholar
• Eto K, Goto S, Shimazaki T, Yoshida M, Sakakibara M, Isshiki T, et al. Two distinct mechanisms are involved in stent thrombosis under flow conditions. Platelets 2001; 12: 228–235
   PubMed Web of Science ®Google Scholar
• Felder Ch B, Blanco-Prieto MJ, Heizmann J, Merkle HP, Gander B. Ultrasonic atomization and subsequent polymer desolvation for peptide and protein microencapsulation into biodegradable polyesters. J Microencapsulation 2003; 20: 553–567
   PubMed Web of Science ®Google Scholar
• Finn AV, Nakazawa G, Joner M, Kolodgie FD, Mont EK, Gold HU, et al. Vascular responses to drug eluting stents—importance of delayed healing. Arterioscler Thromb Vasc Biol 2007; 27: 1500–1510
   PubMed Web of Science ®Google Scholar
• Fraker PJ, Speck JC. Protein and cell-membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem Biophys Res Commun 1978; 80: 849–857
   PubMed Web of Science ®Google Scholar
• Gaikwad SG, Reddy VC, Pandit AB. Ultrasonic atomisation: A novel technique for surface coatings. Surf Coating Int B Coating Trans 2005; 88: 189–196
   Web of Science ®Google Scholar
• Investigators E. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998; 352: 87–92
   PubMed Web of Science ®Google Scholar
• Investigators TE. Platelet glycoprotein IIb/IIIa blockade and low-dose heparin during percutaneous coronary revascularisation. N Engl J Med 1997; 336: 1689–1696
   PubMed Web of Science ®Google Scholar
• Jaster M, Horstkotte D, Willich T, Stellbaurn C, Knie W, Spencker S, et al. The amount of fibrinogen-positive platelets predicts the occurrence of in-stent restenosis. Atherosclerosis 2008; 197: 190–196
   PubMed Web of Science ®Google Scholar
• Jeong M, Owen W, Staab M, Srivatsa S, Sangiorgi G, Stewart M, et al. Does heparin release coating of the Wallstent limit thrombosis and platelet deposition?: Results in a porcine carotid injury model. [abstract]. Circulation 1995; 92: I–37
   Web of Science ®Google Scholar
• Kim W, Jeong MH, Hong YJ. The long-term clinical results of a platelet glycoprotein IIb/IIIa receptor blocker(abciximab: ReoProTM) coated stent in patients with coronary artery disease. Korean J Intern Med 2004; 19: 220–229
   PubMedGoogle Scholar
• Lozano A, Amaveda H, Barreras F, Jorda X, Lozano M. High-frequency ultrasonic atomization with pulsed excitation. J Fluids Eng 2003; 125: 941–945
   Web of Science ®Google Scholar
• Ma XY, Li ZY. M LJ. 2005, China Patent No. ZL1605366A
   Google Scholar
• Ma XY, Li ZY. M LJ. 2006, China Patent No. ZL2749469Y
   Google Scholar
• Maisel WH. Unanswered questions—drug-eluting stents and the risk of late thrombosis. N Engl J Med 2007; 356: 981–984
   PubMed Web of Science ®Google Scholar
• Mitra AK, Agrawal DK. In stent restenosis: Bane of the stent era. J Clin Pathol 2006; 59: 232–239
   PubMed Web of Science ®Google Scholar
• Montjovent MO, Mathieu L, Hinz B, Applegate LL, Bourban PE, Zambelli PY, et al. Biocompatibility of bioresorbable poly(L-lactic acid) composite scaffolds obtained by supercritical gas foaming with human fetal bone cells. Tissue Eng 2005; 11: 1640–1649
   PubMedGoogle Scholar
• Nakayama Y, Nishi S, Ishibashi-Ueda H. Fabrication of drug-eluting covered stents with micropores and differential coating of heparin and FK506. Cardiovasc Radiat Med 2003; 4: 77–82
   PubMedGoogle Scholar
• Pavanetto F, Genta I, Giunchedi P, Conti B. Evaluation of spray drying as a method for polylactide and polylactide-co-glycolide microsphere preparation. J Microencapsulation 1993; 10: 487–497
   PubMed Web of Science ®Google Scholar
• Rajan R, Pandit AB. Correlations to predict droplet size in ultrasonic atomisation. Ultrasonics 2001; 39: 235–255
   PubMed Web of Science ®Google Scholar
• Ranade SV, Miller KM, Richard RE, Chan AK, Allen MJ, Helmus MN. Physical characterization of controlled release of paclitaxel from the TAXUS(TM) Express(2TM) drug-eluting stent. J Biomed Mater Res 2004; 71A: 625–634
   Web of Science ®Google Scholar
• Ratner BD, Hoffman AS. Biomaterials science—An introduction to materials in medicine. Elsevier Academic Press, San Diego 1996
   Google Scholar
• Schwartz RS, Edelman ER, Consensus C. Drug-eluting stents in preclinical studies—recommended evaluation from a consensus group. Circulation 2002; 106: 1867–1873
   PubMed Web of Science ®Google Scholar
• Serruys PW, Daemen J. Late stent thrombosis a nuisance in both bare metal and drug-eluting stents. Circulation 2007; 115: 1433–1439
   PubMed Web of Science ®Google Scholar
• Sheng M, Hu X, Ruan C. Inhibition of angiogenesis properties by SZ-21. J Exp Hematol 2003; 11: 74–80
   Google Scholar
• Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology—drug-eluting stents: Part I. Circulation 2003; 107: 2274–2279
   PubMed Web of Science ®Google Scholar
• Sousa JE, Serruys PW, Costa MA. New frontiers in cardiology—drug-eluting stents: Part II. Circulation 2003; 107: 2383–2389
   PubMed Web of Science ®Google Scholar
• Srivatsa SS, Fitzpatrick LA, Tsao PW, Reilly TM, Holmes DR, Schwartz RS, et al. Selective alpha v beta 3 integrin blockade potently limits neointimal hyperplasia and lumen stenosis following deep coronary arterial stent injury: Evidence for the functional importance of integrin alpha v beta 3 and osteopontin expression during neointima formation. Cardiovasc Res 1997; 36: 408–428
   PubMed Web of Science ®Google Scholar
• Stamboulis A, Hench LL. Bioresorbable polymers: Their potential as scaffolds for Bioglass (R) composites. Bioceramics 2000; 192–1: 729–732
   Google Scholar
• Tam SH, Sassoli PM, Jordan RE, Nakada MT. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta(3) integrins. Circulation 1998; 98: 1085–1091
   PubMed Web of Science ®Google Scholar
• Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ Res 1998; 82: 396–403
   PubMed Web of Science ®Google Scholar
• Tsai SC, Childs P, Luu P, Teshome A, Tsai CS. Air-assisted ultrasonic atomization. Presented at Ultrasonics Symposium. IEEE. 1996
   Google Scholar
• Tsai SC, Luu P, Song YL, Tsai CS, Lin HM. Ultrasound-enhanced atomization of polymer solutions and applications to nanoparticles synthesis. San Juan, Puerto Rico 2000
   Google Scholar
• Verhoeven M, Driessen AAG, Paul AJ, Brown A, Canry JC, Hendriks M. DSIMS characterization of a drug-containing polymer-coated cardiovascular stent. J Contr Rel 2004; 96: 113–121
   PubMed Web of Science ®Google Scholar
• Waksman R. Drug-eluting stents: From bench to bed. Cardiovasc Radiat Med 2002; 3: 226–241
   PubMedGoogle Scholar
• Yasuda K, Bando Y, Yamaguchi S, Nakamura M, Oda A, Kawase Y. Analysis of concentration characteristics in ultrasonic atomization by droplet diameter distribution. Ultrason Sonochem 2005; 12: 37–41
   PubMed Web of Science ®Google Scholar
• Yin TY, Wang GX, Ruan CG, Guzman R, Guidoin R. In-vitro assays of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor monoclonal antibody. J Biomed Mater Res A 2007; 83A: 861–867
   Web of Science ®Google Scholar